{
    "2018-07-31": [
        [
            {
                "time": "2018-01-02",
                "original_text": "U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict",
                "features": {
                    "keywords": [
                        "insurers",
                        "exposure",
                        "J&J",
                        "talc",
                        "verdict"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "insurance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-25",
                "original_text": "A Look at Dentsply Sirona’s Expected Bottom Line in Q2 2018",
                "features": {
                    "keywords": [
                        "Dentsply",
                        "Sirona",
                        "Bottom Line",
                        "Q2 2018"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dentistry",
                        "medical devices"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "Why Editas Medicine Stock Fell in July",
                "features": {
                    "keywords": [
                        "Editas Medicine",
                        "Stock Fell",
                        "July"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "Pfizer Beat Wall Street Analyst Estimates for Q2 2018 Earnings",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Beat",
                        "Wall Street",
                        "Analyst Estimates",
                        "Q2 2018 Earnings"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-03",
                "original_text": "Pfizer CEO expects Trump to eliminate drug rebates",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CEO",
                        "Trump",
                        "drug rebates"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-08-04",
                "original_text": "What to Expect for DaVita’s Q2 2018 Earnings",
                "features": {
                    "keywords": [
                        "DaVita",
                        "Q2 2018 Earnings"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare services"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-05",
                "original_text": "Pfizer (PFE) Beats on Q2 Earnings & Sales, Ups Profit View",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Beats",
                        "Q2 Earnings",
                        "Sales",
                        "Profit View"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}